TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Talecris Biotherapeutics Holdings Corp. Board Under Investigation for Accepting the Grifols Offer

  • If you currently hold shares of Talecris Biotherapeutics Holdings Corp (NASDAQ:TLCR), you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

After the Talecris Biotherapeutics Holdings board of directors agreed to the proposal by Grifols to take over Talecris Biotherapeutics Holdings Corp an investigation on behalf of current investors Talecris Biotherapeutics Holdings Corp (NASDAQ:TLCR) over possible breaches of fiduciary duty by the board of directors of Talecris Biotherapeutics Holdings Corp was announced. The investig...



You must register (for free) or login to view the entire investigation.

Click here to Sign In or Register (for a free account)

@screen width:
@theme:
@breakpoints:
@layout: